A Phase III, Randomized, Placebo-controlled, Double-blin

Project: Research project

Project Details

Description

A Phase III, Randomized, Placebo-controlled, Double-blind Study to Assess the Efficacy and Safety of Once-daily Orally Administered ZD4054 10 mg in Non-metastatic Hormone-resistant Prostate Cancer Patients
StatusFinished
Effective start/end date7/1/0912/31/11

Funding

  • AstraZeneca

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.